NCT05107388
Source recordAI-normalized
AAREN: Continuous Glucose Monitoring Profile Description Under Alpelisib treAtment in Patients With Advanced bREast Cancer
The purpose of this study is to describe the glycemic profile of postmenopausal women treated with alpelisib plus fulvestrant using a continuous blood sugar monitoring device (FreeStyle Libre Pro) over 14 days
AI analysis
Indication: Breast Cancer
Modality: medical device
Target: FreeStyle Libre Pro
Sponsor: Centre Hospitalier Universitaire de Besancon
Source URL: ClinicalTrials.gov
Source updated: Nov 04, 2021
Ingested: Jun 07, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: FreeStyle Libre Pro
View original source fields
Condition raw: Breast Cancer, Diabetes
Condition normalized: Breast Cancer, Diabetes
Modality raw: medical device
Modality normalized: medical device
Target raw: FreeStyle Libre Pro
Target normalized: FreeStyle Libre Pro